Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling
PaperCitations, authors & open-access status
Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 52 citations, 2021 year and closed oa status.
52
Citations
2021
Year
closed
OA Status